These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24348883)

  • 1. The speakers' bureau system: a form of peer selling.
    Reid L; Herder M
    Open Med; 2013; 7(2):e31-9. PubMed ID: 24348883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical speakers' bureaus, academic freedom, and the management of promotional speaking at academic medical centers.
    Boumil MM; Cutrell ES; Lowney KE; Berman HA
    J Law Med Ethics; 2012; 40(2):311-25. PubMed ID: 22789048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physicians and the drug industry. "To be like that, you'd better be married."].
    Peiró S
    Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926
    [No Abstract]   [Full Text] [Related]  

  • 6. The ethics of the medical-pharmaceutical relationship.
    Vashi NA; Latkowski JA
    Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
    Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE
    Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national survey of physician-industry relationships.
    Sade RM
    N Engl J Med; 2007 Aug; 357(5):507; author reply 508. PubMed ID: 17671263
    [No Abstract]   [Full Text] [Related]  

  • 9. How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
    Wager E
    BMJ; 2003 May; 326(7400):1196-8. PubMed ID: 12775623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US specialty societies are urged to adopt code on relations with industry.
    Tanne JH
    BMJ; 2010 Apr; 340():c2246. PubMed ID: 20418248
    [No Abstract]   [Full Text] [Related]  

  • 11. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing HPV vaccine: implications for adolescent health and medical professionalism.
    Rothman SM; Rothman DJ
    JAMA; 2009 Aug; 302(7):781-6. PubMed ID: 19690311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry relationships between physicians and professional medical associations: corrupt or essential?
    Smith CD; MacFadyen B
    Surg Endosc; 2010 Feb; 24(2):251-3. PubMed ID: 20087748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond a pejorative understanding of conflict of interest.
    Williams-Jones B
    Am J Bioeth; 2011 Jan; 11(1):1-2. PubMed ID: 21240793
    [No Abstract]   [Full Text] [Related]  

  • 15. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 16. Physicians and drug representatives: exploring the dynamics of the relationship.
    Chimonas S; Brennan TA; Rothman DJ
    J Gen Intern Med; 2007 Feb; 22(2):184-90. PubMed ID: 17356984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK nixing physician dollars: other companies not to follow suit.
    Berger E
    Ann Emerg Med; 2014 Jun; 63(6):19A-21A. PubMed ID: 24967442
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations.
    Rosenbaum L
    N Engl J Med; 2015 May; 372(19):1860-4. PubMed ID: 25946288
    [No Abstract]   [Full Text] [Related]  

  • 19. Roche defends buying lavish meals for doctors at Sydney's restaurants.
    Moynihan R
    BMJ; 2006 Jul; 333(7560):169. PubMed ID: 16858041
    [No Abstract]   [Full Text] [Related]  

  • 20. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.